The management of systemic lupus erythematosus: Facts and controversies

被引:7
作者
Elbirt, Daniel [1 ]
Sthoeger, Dalia [2 ]
Asher, Ilan [1 ]
Sthoeger, Zev Moshe [1 ]
机构
[1] Hadassah Hebrew Univ, Sch Med, Dept Med B, Clin Immunol Allergy & AIDS Ctr,Kaplan Med Ctr, IL-76100 Rehovot, Israel
[2] Hadassah Hebrew Univ, Sch Med, Kaplan Med Ctr, Dept Pediat, IL-76100 Rehovot, Israel
关键词
COMPLEMENTARITY-DETERMINING REGION-1; STEM-CELL TRANSPLANTATION; ANTI-CD40 LIGAND ANTIBODY; DOUBLE-BLIND; MYCOPHENOLATE-MOFETIL; MONOCLONAL-ANTIBODY; LONG-TERM; RITUXIMAB TREATMENT; DISEASE-ACTIVITY; B-LYMPHOCYTE;
D O I
10.1016/j.clindermatol.2009.06.017
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Systemic lupus erythematosus is a multisystem disease of unknown etiology in which dysregulation of the innate and adaptive immune systems has a major effect in the pathogenesis of the disease. The treatment should be tailored for each patient according to how the disease manifests itself. Although there is no cure for systemic lupus erythematosus, the current treatment, using anti-inflammatory, antimalarial, and immunosuppressive agents, is fairly effective, but serious adverse events are possible. New biologic agents that target various components of the immune system recently have been developed for the treatment of patients with systemic lupus erythematosus. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:330 / 336
页数:7
相关论文
共 54 条
  • [1] CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice
    Akkerman, A
    Huang, WQ
    Wang, XB
    Ramanujam, M
    Schiffer, L
    Madio, M
    Factor, SM
    Davidson, A
    [J]. AUTOIMMUNITY, 2004, 37 (6-7) : 445 - 451
  • [2] LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus -: Results from a randomized, double-blind, placebo-controlled study
    Alarcón-Segovia, D
    Tumlin, JA
    Furie, RA
    McKay, JD
    Cardiel, MH
    Strand, V
    Bagin, RG
    Linnik, MD
    Hepburn, B
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 442 - 454
  • [3] ARANOW C, 2003, RHAUMATOLOGY, P1395
  • [4] EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics
    Bertsias, G.
    Ioannidis, J. P. A.
    Boletis, J.
    Bombardieri, S.
    Cervera, R.
    Dostal, C.
    Font, J.
    Gilboe, I. M.
    Houssiau, F.
    Huizinga, T.
    Isenberg, D.
    Kallenberg, C. G. M.
    Khamashta, M.
    Piette, J. C.
    Schneider, M.
    Smolen, J.
    Sturfelt, G.
    Tincani, A.
    van Vollenhoven, R.
    Gordon, C.
    Boumpas, D. T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) : 195 - 205
  • [5] B lymphocytes and lupus nephritis: New insights into pathogenesis and targeted therapies
    Bhat, P.
    Radhakrishnan, J.
    [J]. KIDNEY INTERNATIONAL, 2008, 73 (03) : 261 - 268
  • [6] Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus
    Blanco, P
    Palucka, AK
    Gill, M
    Pascual, V
    Banchereau, J
    [J]. SCIENCE, 2001, 294 (5546) : 1540 - 1543
  • [7] Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis
    Boletis, JN
    Ioannidis, JPA
    Boki, KA
    Moutsopoulos, HM
    [J]. LANCET, 1999, 354 (9178) : 569 - 570
  • [8] A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis
    Boumpas, DT
    Furie, R
    Manzi, S
    Illei, GG
    Wallace, DJ
    Balow, JE
    Vaishnaw, A
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (03): : 719 - 727
  • [9] The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus:: A randomized trial
    Buyon, JP
    Petri, MA
    Kim, MY
    Kalunian, KC
    Grossman, J
    Hahn, BH
    Merrill, JT
    Sammaritano, L
    Lockshin, M
    Alarcón, GS
    Manzi, S
    Belmont, HM
    Askanase, AD
    Sigler, L
    Dooley, MA
    Von Feldt, J
    McCune, WJ
    Friedman, A
    Wachs, J
    Cronin, M
    Hearth-Holmes, M
    Tan, M
    Licciardi, F
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (12) : 953 - 962
  • [10] Abetimus sodium for renal flare in systemic lupus erythematosus
    Cardiel, Mario H.
    Tumlin, James A.
    Furie, Richard A.
    Wallace, Daniel J.
    Joh, Tenshang
    Linnik, Matthew D.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (08): : 2470 - 2480